文献速递妇科

生物补片微创骶骨固定术的移植物并发症与复发系统综述

A Systematic Review of Graft-Related Complications and Recurrence Following Minimally Invasive Sacrocolpopexy With Xenografts and Allografts.
PubMed 文献 · BJOG · 2026-03-02

该系统综述与荟萃分析评估了微创骶骨固定术(MISC)使用生物补片后的复发率和移植物相关并发症(GRC)。纳入5项研究共353例患者,汇总复发率为25.6%(95%CI:8.1%-48.2%),补片暴露率为0.8%(95%CI:0.0%-4.2%),复发再手术率为16.8%(95%CI:0.0%-51.7%)。结论提示生物补片复发率高于文献中合成补片的典型报告,而暴露率似乎相当,但研究异质性大,需进一步研究确定最佳补片选择。

要点

  • 生物补片MISC汇总复发率25.6%,补片暴露率0.8%。
  • ADM复发率最低(2.4%)且无暴露报告。
  • Tutoplast尸体阔筋膜复发率最高(52.6%),暴露率5.3%。

核心结论

  • 生物补片MISC的复发率高于其他文献中合成补片的典型报告,而暴露率似乎相当。
  • 鉴于研究异质性,需进一步研究确定兼顾 durability 与并发症风险的最佳补片选择。

研究设计与样本

  • 系统综述与随机效应荟萃分析,检索PubMed、Embase和Cochrane数据库至2024年8月。
  • 纳入标准为≥10例患者接受生物补片MISC、报告复发或GRC且随访≥6个月的研究。
  • 共纳入5项研究,353例患者;两名独立评审者使用NOS评估研究质量。

主要发现

  • 复发率范围为2.4%至52.6%,汇总复发率为25.6%(95%CI:8.1%-48.2%)。
  • 补片暴露率为0.8%(95%CI:0.0%-4.2%)。
  • ADM复发率最低(2.4%)且无暴露报告;Tutoplast尸体阔筋膜复发率最高(52.6%),暴露率5.3%。
  • 复发再手术率汇总为16.8%(95%CI:0.0%-51.7%)。

临床怎么用

  • 临床选择生物补片行MISC时需权衡较高的复发风险与较低的补片暴露率。
  • 不同生物补片材料结局差异大,ADM复发率最低而Tutoplast尸体阔筋膜复发率最高。

局限性

  • 纳入研究数量少(5项),样本量有限(353例),研究间异质性大。
  • 生物补片复发率与合成补片的比较基于其他文献的典型报告,非直接头对头比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biological grafts are proposed as an alternative to synthetic grafts in sacrocolpopexy (SC) to reduce complications such as graft exposure and immunologic reactions. However, concerns remain long-term durability. This systematic review and meta-analysis assess recurrence rates and graft-related complications (GRC) in minimally invasive sacrocolpopexy (MISC) using biological grafts. OBJECTIVES: To evaluate the recurrence and GRC following MISC with biological grafts and to compare outcomes across different materials. SEARCH STRATEGY: PubMed, Embase and Cochrane databases were searched up to August 2024. SELECTION CRITERIA: Studies with ≥ 10 patients undergoing MISC with biological grafts, reporting recurrence or GRC with ≥ 6 months follow-up, were included. DATA COLLECTION AND ANALYSIS: Two independent reviewers assessed study quality using the Newcastle-Ottawa Scale (NOS). A random-effects meta-analysis estimated pooled recurrence and GRC with 95% confidence intervals (CI). MAIN RESULTS: Five studies (353 patients) met inclusion criteria. Recurrence rates ranged from 2.4% to 52.6% (pooled: 25.6% [95% CI: 8.1%-48.2%]). Graft exposure occurred in 0.8% (95% CI: 0.0%-4.2%). ADM had the lowest recurrence (2.4%) with no reported exposures, whereas Tutoplast cadaveric fascia lata showed the highest recurrence (52.6%) and exposure (5.3%). The pooled reoperation rate for recurrence was 16.8% (95% CI: 0.0%-51.7%). CONCLUSION: This systematic review identified a higher recurrence rate with biological grafts in MISC than typically reported for synthetic grafts in other literature, while exposure rates appeared to be comparable. Given study heterogeneity, further research is required to determine the optimal graft choice balancing durability and complication risk.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Boom MA, van Genderen M, Verheijen PM, et al. A Systematic Review of Graft-Related Complications and Recurrence Following Minimally Invasive Sacrocolpopexy With Xenografts and Allografts. BJOG. 2026. PMID: 41771773. doi:10.1111/1471-0528.70184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。